RECALL RECORD — CLASS IIRecall closedF-0989-2023/FDA enforcement

Tyr Anamix Early Years Infant Formula NET WT

What you need to know

Class II
  • What happened

    Infant formula contains undeclared tyrosine

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. An allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

  • Action required

    Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction.

Recall closed · classified by the FDADistribution not listedMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameNutricia North America
Recalling firmNutricia North AmericaRockville, MD, United States
UPC / barcodes
7 49735 00218 67 49735 10218 3
Lot / date codes
  • Expiration date: 03/30/2024 Batch/lot code 101175408 Case EAN code: 749735102183 Vendor product code: 90218
Distribution area

Alaska, California, Connecticut, Florida, Illinois, Kansas, Louisiana, Maine, Minnesota, Mississippi, Nebraska, New Mexico, New York, Ohio, Pennsylvania, Tennessee, Texas, Utah, Virginia, Vermont, Washington and Puerto Rico.

Mexico, Puerto Rico

Quantity affected94 cans
Recall initiationFDA report date: June 28, 2023
FDA recall numberF-0989-2023

Beyond the headline

The recall, in context

Nutricia North America initiated this food recall on May 17, 2023. The FDA enforcement report states: Infant formula contains undeclared tyrosine. The FDA report lists distribution as: Alaska, California, Connecticut, Florida, Illinois, Kansas, Louisiana, Maine, Minnesota, Mississippi, Nebraska, New Mexico, New York, Ohio, Pennsylvania, Tennessee, Texas, Utah, Virginia, Vermont, Washington and Puerto Rico.

The FDA enforcement report describes the reason as: Infant formula contains undeclared tyrosine

Tyr Anamix Early Years Infant Formula NET WT was made or distributed by Nutricia North America in Rockville, MD, United States. This page reflects FDA report F-0989-2023, dated June 28, 2023.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, an allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared allergen

Symptoms to watch for

Hives, swelling, wheezing, coughing, vomiting, abdominal pain or a drop in blood pressure. Anaphylaxis is a medical emergency.

When symptoms may appear

Allergic reactions often begin within minutes to a few hours of eating the allergen.

Higher-risk groups

Anyone with a diagnosed food allergy, especially children, and people with a history of anaphylaxis or asthma.

What to do now

  1. 1Do not eat or serve the affected product if you or anyone in the household has a diagnosed allergy.
  2. 2If symptoms such as swelling, wheezing or breathing difficulty occur, use the person's prescribed emergency plan and call emergency services.
  3. 3Keep the packaging, contact the retailer or manufacturer for a refund, and read the official recall notice for the exact allergen.

For a severe allergic reaction, do not wait for a callback or refund process before seeking emergency care.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Tyr Anamix Early Years Infant Formula NET WT recall?

Nutricia North America recalled Tyr Anamix Early Years Infant Formula NET WT in an FDA Class II enforcement action reported as F-0989-2023. Infant formula contains undeclared tyrosine

What should I do if I bought this product?

Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction. Do not eat or serve the affected product if you or anyone in the household has a diagnosed allergy. If symptoms such as swelling, wheezing or breathing difficulty occur, use the person's prescribed emergency plan and call emergency services. Keep the packaging, contact the retailer or manufacturer for a refund, and read the official recall notice for the exact allergen.

Is the Nutricia North America recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0989-2023. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Nutricia North America

View brand

Related alerts

Recent Undeclared allergens recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.